Floatz logo

ANDROSTANE-3,17-DIOL, 16-(1-METHYL-1-PIPERIDINIUMYL)-2-(1-PIPERIDINYL)-, DIACETATE (ESTER), (2.BETA.,3.ALPHA.,5.ALPHA.,16.BETA.,17.BETA.)-

Stroke

The University of Texas Health Science Center, HoustonSmall moleculePhase 4 / ApprovedDormant
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
65/ 100

Competitive context

141 Active assets in the Stroke cohort.

Asset / SponsorPhaseRating
Tenecteplase
Assistance Publique - Hôpitaux de Paris
Phase 4BBB
Rivaroxaban
China National Center for Cardiovascular Diseases
Phase 4BBB
Lipitor
Duan Chuanzhi
Phase 4BB
Ticagrelor
Assistance Publique - Hôpitaux de Paris
Phase 4BB
Plavix
Shanghai CureGene Pharmaceutical Co., Ltd.
Phase 4BB

View all 50 →

Same molecule, other indications

ANDROSTANE-3,17-DIOL, 16-(1-METHYL-1-PIPERIDINIUMYL)-2-(1-PIPERIDINYL)-, DIACETATE (ESTER), (2.BETA.,3.ALPHA.,5.ALPHA.,16.BETA.,17.BETA.)- is also rated in:

neuromuscular junction diseaseDormant
BB
Indicative ·
69 / 100
View asset →
Uterine DiseasesDormant
D
Indicative ·
30 / 100
View asset →
Uterine NeoplasmsDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →